Pancreatic Cancer Research

ResearcherIndian Institute of Integrative MedicineNo recent work listed

Sandip Bibishan Bharate

Matched on ORCID iD 0000-0001-6081-5787; OpenAlex author ID A5024494535.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Orally bioavailable styryl derivative of rohitukine-N-oxide inhibits CDK9/T1 and the growth of pancreatic cancer cells. Last author DOI 10.1016/j.ejmech.2023.115533↗
  2. A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer … Co-author DOI 10.1007/s13277-016-5160-5↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Deendyal Bhurta · 1 shared paper, 2023
  2. Ashok Kumar · 1 shared paper, 2016
  3. Dilip Manikaro Mondhe · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.